e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled iloprost suppresses the cardinal features of asthma
via
inhibition of airway dendritic cell function
M. Idzko, H. Hammad, M. van Nimwegen, H. Hoogsteden, B. Lambrecht (Rotterdam, Netherlands; Freiburg, Germany)
Source:
Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Session:
Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Session type:
Electronic Poster Discussion
Number:
2986
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Idzko, H. Hammad, M. van Nimwegen, H. Hoogsteden, B. Lambrecht (Rotterdam, Netherlands; Freiburg, Germany). Inhaled iloprost suppresses the cardinal features of asthma
via
inhibition of airway dendritic cell function. Eur Respir J 2007; 30: Suppl. 51, 2986
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 24s
Year: 2007
Inhaled corticosteroids and growth of airway function in asthmatic children
Source: Eur Respir J 2004; 23: 861-868
Year: 2004
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Source: Eur Respir J 2006; 27: 172-187
Year: 2006
Formoterol protects against platelet-activating factor-induced effects in asthma
Source: Eur Respir J 2004; 23: 71-75
Year: 2004
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma
Source: Eur Respir J 2002; 20: 853-858
Year: 2002
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
Budesonide reverses IL-13–induced airway hyper-responsiveness but has little effect on β2 agonist response in human small airways
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
Source: Eur Respir J 2007; 30: 653-661
Year: 2007
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma
Source: Eur Respir J 2002; 19: 872-878
Year: 2002
Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012
Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012
Evidence of a distinct phenotype of adult onset asthma characterized by an airway neutrophilia and poor response to inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001
Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells
Source: Eur Respir J 2004; 24: Suppl. 48, 251s
Year: 2004
IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 50s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept